# Effect of Boswellia Sacra as an Intracanal Medicament on Postoperative Pain Intensity and Bacterial Load Reduction

> **NCT05820646** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 45 (estimated)

## Conditions studied

- Intervention

## Interventions

- **OTHER:** Boswellia Sacra

## Key facts

- **NCT ID:** NCT05820646
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05
- **Primary completion:** 2024-07
- **Final completion:** 2024-08
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820646, "Effect of Boswellia Sacra as an Intracanal Medicament on Postoperative Pain Intensity and Bacterial Load Reduction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05820646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*